Skip to Content

Next-Generation Sequencing

Providing clarity and
actionable results

The diagnosis of bleeding and thrombosing disorders relies heavily on specialized coagulation assays, but genotype assays are increasing in utility and availability.

Next-generation sequencing (NGS) testing can provide useful information that assists physicians including:

  • Confirming the diagnosis of bleeding and thrombotic disorders
  • Providing clarity and actionable results in situations where other testing methodologies provide inconclusive results for patients
  • Identifying mutations that could explain patients’ unusual hemostatic phenotype and laboratory results


Created to meet the growing needs of our own clinical practice, Mayo Clinic now offers a comprehensive NGS full-gene sequencing menu for patients with bleeding and thrombosing disorders.

Which test should I order?


A Test in Focus

Rajiv Pruthi, M.B.B.S., gives an overview of this testing available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to previous testing approaches, and what clinical action can be taken due to the results of this testing.

Learn more about how to order this evaluation at your institution.